nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepyramine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.126	0.154	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0343	0.0419	CbGpPWpGaD
Mepyramine—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.0341	0.187	CrCbGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0336	0.041	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0288	0.0352	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0282	0.0345	CbGpPWpGaD
Mepyramine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.0277	0.152	CrCbGaD
Mepyramine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.0262	0.144	CrCbGaD
Mepyramine—SLC22A4—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0227	0.0277	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0203	0.0249	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0196	0.0239	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0189	0.0231	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0183	0.0224	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.018	0.022	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0178	0.0217	CbGpPWpGaD
Mepyramine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0174	0.0212	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0171	0.0209	CbGpPWpGaD
Mepyramine—SLC22A5—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.017	0.0208	CbGpPWpGaD
Mepyramine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.0169	0.0926	CrCbGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0166	0.0202	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0159	0.0194	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0154	0.0188	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0151	0.0185	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0149	0.0183	CbGpPWpGaD
Mepyramine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.0142	0.0779	CrCbGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0139	0.017	CbGpPWpGaD
Mepyramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.013	0.0159	CbGpPWpGaD
Mepyramine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.0126	0.0692	CrCbGaD
Mepyramine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.0122	0.0672	CrCbGaD
Mepyramine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.012	0.066	CrCbGaD
Mepyramine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0116	0.0142	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0115	0.0141	CbGpPWpGaD
Mepyramine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.0112	0.0613	CrCbGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.011	0.0134	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00975	0.0119	CbGpPWpGaD
Mepyramine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00937	0.0115	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00866	0.0106	CbGpPWpGaD
Mepyramine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	0.00847	0.0465	CrCbGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00826	0.0101	CbGpPWpGaD
Mepyramine—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00789	0.00964	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00661	0.00808	CbGpPWpGaD
Mepyramine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	0.00654	0.0359	CrCbGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00648	0.00792	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00643	0.00786	CbGpPWpGaD
Mepyramine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00593	0.00725	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00567	0.00693	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00555	0.00679	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00449	0.00549	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00431	0.00527	CbGpPWpGaD
Mepyramine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00425	0.00519	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00423	0.00517	CbGpPWpGaD
Mepyramine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00414	0.00507	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00401	0.0049	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00392	0.0048	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00385	0.0047	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00365	0.00446	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00363	0.00444	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00353	0.00432	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00347	0.00425	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00343	0.00419	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00336	0.00411	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0033	0.00404	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0032	0.00391	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00313	0.00382	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00303	0.0037	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00301	0.00368	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00298	0.00364	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00294	0.00359	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00293	0.00358	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0029	0.00354	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00274	0.00335	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00259	0.00317	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00256	0.00313	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00244	0.00298	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00239	0.00292	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00238	0.00291	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00231	0.00282	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00227	0.00278	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00227	0.00277	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00226	0.00276	CbGpPWpGaD
Mepyramine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00224	0.00274	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00224	0.00274	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00224	0.00274	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00221	0.00271	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00217	0.00265	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00209	0.00255	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00195	0.00238	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00192	0.00234	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00166	0.00202	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00152	0.00186	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0015	0.00184	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00179	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00145	0.00177	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00135	0.00164	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00131	0.00161	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00131	0.0016	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0013	0.00159	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00128	0.00157	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.00157	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00126	0.00155	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00126	0.00154	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00122	0.00149	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00118	0.00145	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00118	0.00144	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00116	0.00142	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00115	0.0014	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00107	0.00131	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000929	0.00114	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000888	0.00109	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000825	0.00101	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000776	0.000949	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000749	0.000916	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000722	0.000882	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000699	0.000855	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000687	0.00084	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000679	0.00083	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000641	0.000784	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000641	0.000784	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000632	0.000773	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000631	0.000772	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000587	0.000717	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000513	0.000627	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000488	0.000597	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000443	0.000541	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000389	0.000475	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000386	0.000472	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000235	0.000287	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000167	0.000204	CbGpPWpGaD
